Jolly Good Launches R&D of VR Therapy for Chronic Pain with Aichi Medical University’s Pain Center.

Jolly Good Inc., in collaboration with Aichi Medical University Hospital’s Pain Center, the first interdisciplinary treatment and research facility for pain in Japan, will research the efficacy of VR therapy for chronic pain.

Professor Takahiro Ushida, one of Japan’s leading experts in pain treatment, will collaborate in this research. This research will be conducting multifaceted research on the use of VR in diverse situations, such as rehabilitation of patients, to develop VR therapy for chronic pain. Professor Ushida has represented Japan in the revision of the definition of pain by the International Association for the Study of Pain.

Recommended AI News: TheViewPoint Integrates With BidSwitch for Streamlined Access to the Global Programmatic Demand Ecosystem

In the first phase of this research, Jolly Good and Aichi Medical University plan to study the development of rehabilitation therapy using VR for people with complex regional pain syndrome (CRPS), post-stroke pain, and other conditions that cause pain or fear of movement.

Aichi Medical University Hospital’s Pain Center was established as Japan’s first interdisciplinary pain treatment and research facility, dedicated to the principle that management of pain should be addressed beyond the boundaries of departments and disciplines.

Here, experts from different departments and disciplines work together to provide interdisciplinary treatment. The Pain Center also works on clarifying basic pain mechanisms and developing treatments.

Recommended AI News: Recruitology and VONQ Partner to Deliver Job Distribution for VONQ Clients

“Most patients who visit our Pain Center suffer from pain for a long time, and they have difficulty leading their daily lives. Although the determination of the pain source and treatment is essential, chronic pain cases are complicated. Due to the vicious cycle (pain experience → anxiety → change in lifestyle → worsening of pain), negative experiences remain deep in the patient’s brain and body, which greatly strengthen the symptoms.

We think that rehabilitation using virtual reality can induce and accumulate successful experiences, which could improve physical condition and pain. This collaborative research will develop a new treatment for chronic pain by combining our clinical knowledge with Jolly Good’s ultra-realistic VR technology.”

In April 2020, Jolly Good established the DTx Division, a specialized team for developing digital therapies that include psychiatrists and pharmaceutical strategy specialists, among others. Building upon the base of the VRDTx system, Jolly Good will expand its pipeline to multiple mental illnesses and lifestyle-related diseases and will develop its digital therapies business both in Japan and overseas.

Recommended AI News: Mobilum Technologies Signs Agreement To Integrate Off-Ramp Services Into The Ledger Live Platform, Gateway For Digital Assets & Web3

[To share your insights with us, please write to sghosh@martechseries.com]